Marganit Farago, Ph.D. - Publications

Affiliations: 
2007 Boston University, Boston, MA, United States 
Area:
Cell Biology, Molecular Biology, Oncology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Shalom B, Farago M, Salaymeh Y, Sebban S, Pikarsky E, Katzav S. Vav1 Promotes B-Cell Lymphoma Development. Cells. 11. PMID 35326399 DOI: 10.3390/cells11060949  0.318
2018 Shalom B, Farago M, Pikarsky E, Katzav S. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes. Oncogenesis. 7: 80. PMID 30297765 DOI: 10.1038/s41389-018-0091-1  0.303
2014 Sebban S, Farago M, Rabinovich S, Lazer G, Idelchuck Y, Ilan L, Pikarsky E, Katzav S. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion. Oncotarget. 5: 9214-26. PMID 25313137 DOI: 10.18632/oncotarget.2400  0.347
2010 Lazer G, Pe'er L, Farago M, Machida K, Mayer BJ, Katzav S. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity. The Journal of Biological Chemistry. 285: 23075-85. PMID 20457609 DOI: 10.1074/Jbc.M109.094508  0.319
2006 Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, Sonenshein GE, Sherr DH. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biological Chemistry. 387: 1175-87. PMID 16972784 DOI: 10.1515/Bc.2006.145  0.588
2005 Seldin DC, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I. CK2 as a positive regulator of Wnt signalling and tumourigenesis. Molecular and Cellular Biochemistry. 274: 63-7. PMID 16342409 DOI: 10.1007/S11010-005-3078-0  0.453
2005 Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZX, Sherr DH, Seldin DC. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicologic Pathology. 33: 726-37. PMID 16263698 DOI: 10.1080/01926230500352226  0.637
2005 Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Research. 65: 5792-801. PMID 15994955 DOI: 10.1158/0008-5472.Can-05-1021  0.757
Show low-probability matches.